Abivax ADR
Abivax ADR (ABVX) Options Open Interest
ABVX options open interest is 186,223 contracts. The 2-week average daily volume is 10,196 contracts across the chain.
Read more
Monitoring ABVX open interest helps you see where real money is positioned on Abivax ADR's options and which strikes are attracting the most commitment from traders. Abivax ADR's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor ABVX options open interest in real time and find the strikes that matter.
Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising ABVX options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Abivax ADR to settle.
ABIVAX Société Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. Its principal products include ABX464 that is in Phase IIb clinical trials for the treatment of ulcerative colitis and Crohn's Disease, as well as for COVID-19; Phase IIa clinical trial for the treatment of rheumatoid arthritis diseases; and has completed Phase IIa clinical trial for the treatment of viral remission in patients with HIV. It also develops ABX 196, an immune enhancer candidate that is in Phase 1/2 clinical trials for the treatment of hepatocellular cancer.
In addition, the company engages in the research programs for the treatment of Dengue fever, influenza, and respiratory syncytial virus. ABIVAX Société Anonyme has license contracts with the French National Centre for Scientific Research, the University of Montpellier, and the Institut Curie. The company was incorporated in 2013 and is headquartered in Paris, France.
Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where ABVX open interest is concentrated. Our scanner maps Abivax ADR's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Abivax ADR's options open interest as the signal it is, not as an afterthought.
| 180.00 | — | 1.15 | 1.15 | 585% | +0.0784 | 1,220 |
| 160.00 | — | 0.05 | 0.05 | 308% | +0.0081 | 1,142 |
| 110.00 | — | 0.20 | 0.20 | 138% | +0.0549 | 814 |
| 100.00 | 0.25 | 0.75 | 0.50 | 89% | +0.1683 | 795 |
| 105.00 | — | 0.60 | 0.60 | 139% | +0.1371 | 765 |
| 90.00 | — | 1.70 | 1.70 | 134% | -0.2960 | 798 |
| 85.00 | — | 0.30 | 0.30 | 113% | -0.0868 | 663 |
| 95.00 | 0.80 | 3.20 | 2.00 | 59% | -0.5796 | 662 |
| 100.00 | 4.60 | 7.00 | 5.80 | 10% | -1.0000 | 510 |
| 80.00 | — | 0.35 | 0.35 | 167% | -0.0700 | 198 |
As of September 23, 2026
Follow the money
Track ABVX open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.
Start your 14-day free trial→